Why Sage Therapeutics CEO Jeff Jonas believes Zulresso will remedy more than postpartum depression
In late June the 400,000 women in the U.S. affected each year with postpartum depression will no longer be forced to endure the extreme sadness, anxiety, exhaustion and other symptoms that define this debilitating, often misunderstood condition. That’s because that’s when Zulresso, the first and only medicine approved by the Food and Drug Administration to… Read More »
